BS Identity and Score for AbbVie Inc.

AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.

B
BS Level
Medical Devices, Pharma & Biotech
40.8 Avg BS

Based on 587 businesses audited.

BS Detector

Medical Devices, Pharma & Biotech BS: AbbVie Inc. (maviret.com)

https://maviret.com 📍 Industry: Medical Devices, Pharma & Biotech
12 BS / 100

This is a high-substance medical property where legal and clinical requirements force the elimination of bullshit. It effectively uses forensic citations to anchor every significant performance claim.

Info Density Power-words vs. Substance ratio.
3
10% BS
Semantic Coherence Homepage promise vs. Sub-page reality.
1
5% BS
Trust & Proof Verifiable evidence vs. Trust Theatre.
4
20% BS
Commodity Fingerprint Detection of industry clichés/templates.
2
13% BS
Identity & Authority Expert verifiability & Schema depth.
2
13% BS

1. Update the patient treatment count footnote, as the 2023 sales data is currently 31 months old (aging). 2. Add outbound links to published clinical trial results on ClinicalTrials.gov to convert footnotes into verified proof paths. 3. Remove or clarify the unverified review_count metadata to prevent it being flagged as trust theatre. 4. Ensure the transcript for the personal message from real patients is indexed to provide further textual evidence of cure claims.

Info Density Power-words vs. Substance ratio.
3 Impact Weight: 30 / 100
10% BS

The site exhibits exceptionally high information density. The H1 Hep C: ONLY 8 WEEKS TO CURE contains a specific noun, number, and outcome, which is the antithesis of fluff. Body text is dominated by specific clinical markers such as genotypes 1 through 6 and chemical components like glecaprevir and pibrentasvir, leaving almost no room for generic marketing filler.

When edges drift or clusters collapse, your content becomes a set of disconnected islands. Inspect your internal link topology to identify where authority flow breaks or never forms.

Semantic Coherence Homepage promise vs. Sub-page reality.
1 Impact Weight: 20 / 100
5% BS

There is zero detectable semantic drift between the homepage hero section and the sub-page content. The homepage promises an 8-week cure, and the What is MAVYRET sub-page provides the technical clinical indication and administration route that supports this claim exactly. The pricing and locator pages are functional extensions of the primary value proposition without any shift in target audience or brand identity.

Our Authority as a Service model transforms raw diagnostic data into high stakes results. Start your Clinical Strategic Diagnosis for 1 Euro to secure the strategic fixes required for growth.

Trust & Proof Verifiable evidence vs. Trust Theatre.
4 Impact Weight: 20 / 100
20% BS

The review_count of 2 is a minor trust theatre flag as it lacks an external verification link. However, this is largely mitigated by the presence of forensic footnotes (indicated by special characters) that cite IQVIA data and Global AbbVie sales estimates. The trust_theatre_flag is true, likely due to the unlinked 1 MILLION treated claim, though the underlying substance is high.

The proof density is high relative to the amount of text. Specific proof points include the treatment count (1 million), the treatment duration (8 weeks), the specific genotypes treated, and the specific IQVIA data period (ending 2025). The ratio of verifiable evidence to vague assertions is approximately 8:1.

To see how the system reconstructs a medical entity graph at scale, review the full Cleveland Clinic Structured Data audit. View the Cleveland Clinic Structured Data Audit for a live example of identity level decomposition and cross page entity mapping.

Commodity Fingerprint Detection of industry clichés/templates.
2 Impact Weight: 15 / 100
13% BS

While the site uses standard pharmaceutical template fingerprints like Patient Resources and For Healthcare Professionals, the content is highly differentiated. The value proposition is tied to a specific patented molecule and clinical result that cannot be copy-pasted onto a competitor. Cliché usage is restricted to functional phrases like Official Site and Meet real patients, which are descriptive rather than hyperbolic.

Identity & Authority Expert verifiability & Schema depth.
2 Impact Weight: 15 / 100
13% BS

The authority is well-established through robust MedicalWebPage schema reviewedBy AbbVie Inc. There are no gaps in expertise, as the site references real patients and HCPs within a framework of clinical data. The technical implementation is clean, with a clear heading hierarchy and specific regulatory disclosures (FDA MedWatch reporting info).

The marketing tone is subdued and clinical, avoiding the typical disconnect found in lower-tier medical sites. Bold claims like 8-week cure are immediately qualified by footnotes defining cure as no virus found 3 months after treatment. This transparency aligns the marketing signal with the clinical substance.

Medical Devices, Pharma & Biotech BS: AbbVie Inc. (maviret.com)

BS: 12/ 100

The site is an exact match for the Pharma & Biotech industry, specifically the therapeutic area of Gastroenterology. It adheres to strict regulatory communication standards by balancing efficacy claims with comprehensive Important Safety Information (ISI).

AI does not interpret your layout visually — it interprets your structure mathematically. Explore the Semantic HTML Technical Framework to understand how heading logic, boundaries, and DOM depth determine what an LLM can retrieve.

“The low BS score of 12 is driven by the extreme specificity of the clinical claims and the robust schema. Points were only awarded for aging sales data and the technical absence of external proof links in the metadata. The site is almost entirely composed of substance.”

Verified Analysis Date: May 30, 2026 © 1EuroSEO Independent Evaluator — Non-Sponsored Result
Get a Strategic Holistic View
FREE TOOLS
BUSINESS STRATEGY

Business Intelligence Engine

×
AI VISIBILITY